14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 CNTA stock ended at $9.25. This is 2.32% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 2.81% from a day low at $9.24 to a day high of $9.50.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Centessa Pharmaceuticals Limited prices

Date Open High Low Close Volume
Aug 24, 2023 $6.79 $6.92 $6.42 $6.59 26 923
Aug 23, 2023 $6.32 $7.01 $6.24 $6.70 43 180
Aug 22, 2023 $6.81 $7.11 $6.40 $6.40 75 456
Aug 21, 2023 $6.27 $7.00 $6.11 $6.81 46 592
Aug 18, 2023 $6.17 $6.77 $6.17 $6.39 27 094
Aug 17, 2023 $6.57 $6.74 $6.10 $6.25 96 562
Aug 16, 2023 $6.82 $6.99 $6.56 $6.56 37 031
Aug 15, 2023 $6.75 $6.95 $6.60 $6.91 33 358
Aug 14, 2023 $6.87 $6.87 $6.40 $6.62 75 379
Aug 11, 2023 $6.50 $7.01 $6.49 $6.67 100 545
Aug 10, 2023 $6.46 $7.41 $6.31 $6.54 187 232
Aug 09, 2023 $6.35 $7.41 $6.35 $6.50 170 059
Aug 08, 2023 $6.32 $6.87 $6.15 $6.35 201 810
Aug 07, 2023 $7.68 $7.68 $6.27 $6.38 194 673
Aug 04, 2023 $7.61 $8.09 $7.43 $7.77 53 748
Aug 03, 2023 $6.88 $7.83 $6.86 $7.59 55 084
Aug 02, 2023 $7.36 $7.77 $6.71 $7.03 2 271 839
Aug 01, 2023 $7.84 $7.84 $7.10 $7.41 83 319
Jul 31, 2023 $7.98 $8.22 $7.52 $7.90 59 271
Jul 28, 2023 $6.70 $7.97 $6.54 $7.97 241 740
Jul 27, 2023 $7.26 $7.50 $6.58 $6.73 292 374
Jul 26, 2023 $7.29 $7.65 $7.05 $7.35 52 764
Jul 25, 2023 $7.09 $7.24 $6.83 $7.14 116 742
Jul 24, 2023 $7.41 $7.41 $6.57 $6.74 150 499
Jul 21, 2023 $7.49 $7.63 $6.77 $7.30 128 168
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT